Terms: = Gastric cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Prognosis
5 results:
1. MAOA suppresses the growth of gastric cancer by interacting with ndrg1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.
Wang YY; Zhou YQ; Xie JX; Zhang X; Wang SC; Li Q; Hu LP; Jiang SH; Yi SQ; Xu J; Cao H; Zhao EH; Li J
Cell Oncol (Dordr); 2023 Oct; 46(5):1429-1444. PubMed ID: 37249744
[TBL] [Abstract] [Full Text] [Related]
2. ndrg1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.
Chang X; Xu X; Ma J; Xue X; Li Z; Deng P; Zhang S; Zhi Y; Chen J; Dai D
Mol Biol Rep; 2014 Sep; 41(9):6215-23. PubMed ID: 24985974
[TBL] [Abstract] [Full Text] [Related]
3. N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1α by human gastric cancer cells.
Murakami Y; Watari K; Shibata T; Uba M; Ureshino H; Kawahara A; Abe H; Izumi H; Mukaida N; Kuwano M; Ono M
J Biol Chem; 2013 Aug; 288(35):25025-25037. PubMed ID: 23846687
[TBL] [Abstract] [Full Text] [Related]
4. N-myc downstream regulated gene 1 (ndrg1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.
Ureshino H; Murakami Y; Watari K; Izumi H; Kawahara A; Kage M; Arao T; Nishio K; Yanagihara K; Kinoshita H; Kuwano M; Ono M
PLoS One; 2012; 7(7):e41312. PubMed ID: 22844455
[TBL] [Abstract] [Full Text] [Related]
5. A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (ndrg1).
Jiang K; Shen Z; Ye Y; Yang X; Wang S
Scand J Gastroenterol; 2010 Aug; 45(7-8):898-908. PubMed ID: 20388062
[TBL] [Abstract] [Full Text] [Related]
